© 2022 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement
gloved hand needle vial vaccine coronavirus
FDA Approves Second COVID Booster for People 50 and Older
Pfizer Paxlovid COVID-19
FDA Authorizes First Antiviral Pill for COVID-19
corona virus covid-19
Questions About COVID-19? Start Here.

HIV Vaccine Awareness Day 2022

What have we learned from the COVID-19 pandemic, and what’s the future of HIV vaccine research? Find out this #HVAD2022.

One Way to Improve Racial and Ethnic Diversity in Clinical Trials

A study found that only 43% of clinical trials reported race and ethnicity. The FDA issued guidance to address these inequalities.

Scientists Identify Characteristics to Better Define Long COVID

Using machine learning, researchers find patterns in electronic health record data to better identify those likely to have the condition.

Why Won’t More Older Americans Get Their Covid Booster?

Approximately 1 in 3 Americans 65 and older who completed their initial vaccination round still have not received a first booster shot.

Cancer Survivors May Not Be at Greater Risk for COVID Complications

People diagnosed with cancer over a year ago and those who were not on treatment did not have a higher risk of hospitalization or death.
3D model of SARS-CoV2 coronavirus (back) and its spike protein (front) that enables the virus to enter human cells.

Intranasal Proteins Could Protect Against COVID-19 Variants

With further testing, the antiviral proteins might be used as a nasal spray to prevent or treat COVID-19.

MUST read

Living with Cancer? Find COVID-19 News Just For You Here.
Living with Liver Disease? Find COVID-19 News Just For You Here.
Living with HIV? Find COVID-19 News Just For You Here.

Still Few Answers as Kids Hepatitis Outbreak Spreads

Nearly 200 cases of pediatric hepatitis have now been reported in more than a dozen countries and several states.

Experts Recommend Fifth COVID-19 Vaccination for Immunocompromised People

National Comprehensive Cancer Network encourages second mRNA booster shot and offers COVID PrEP advice for people with cancer.

Judge’s Ruling on Mask Mandate Highlights the Limits of CDC’s Power

A federal court judge in Florida said the Centers for Disease Control and Prevention had overstepped its authority.
Remdesivir production.

FDA Approves First COVID-19 Treatment for Young Children

Remdesivir (Veklury) is now approved for kids ages 28 days to 12 years.
Novel coronavirus SARS-CoV-2

Nasal Antiviral Blocks SARS-CoV-2 Infection in Mice

Antiviral drugs that target host cells may work against many existing and future variants of the virus that causes COVID-19.

Hot topics

face masks
Face Masks
a US dollar symbol in a life preserver
Health Equity

New Laws Let Visitors See Loved Ones in Health Care Facilities, Even in a COVID Outbreak

New laws make it easier for people to see their loved ones in health care facilities during the pandemic.

Better Ventilation Can Prevent COVID Spread. But Are Companies Paying Attention?

Studies show improved ventilation could be a powerful tool against the coronavirus.

A Majority of People With HIV Have Asymptomatic COVID

The proportion without symptoms was higher than previously seen in many studies of both people with HIV and the general population.

How the Test-to-Treat Pillar of the U.S. COVID Strategy Is Failing Patients

Paxlovid and molnupiravir can reduce the risk of severe COVID-19, but they must be started within five days of symptom onset.
Istock

FDA Authorizes First COVID-19 Breathalyzer Test

The diagnostic test can provide results in less than three minutes.
Advertisement
Newsfeed
Science News

COVID Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

COVID Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.